Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo

Poupart, 1987, B cell growth modulating and differentiating activity of recombinant human 26-kD protein (BSF.2, HuIFN-B2, HPGF), EMBO J., 6, 1219, 10.1002/j.1460-2075.1987.tb02357.x

Kishimoto, 1988, A new interleukin with pleiotropic activities, BioEssays, 9, 11, 10.1002/bies.950090104

Muraguchi, 1988, The essential role of B cell stimulatory factor 2 (BSF-2IL-6) for the terminal differentiation of B cells, J. Exp. Med., 167, 332, 10.1084/jem.167.2.332

Brakenhoff, 1988, Molecular cloning and expression of hybridoma growth factor in Escherichia coli, J. Immunol., 139, 4116, 10.4049/jimmunol.139.12.4116

Gauldie, 1987, Interferon B2B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells, 84, 7251

Kawano, 1988, Autocrine generation and requirement of BSF-2IL-6 for human multiple myelomas, Nature (London), 332, 83, 10.1038/332083a0

Houssiau, 1988, Synergistic activation of human T cells by interleukin 1 and interleukin 6, Eur. J. Immunol., 18, 653, 10.1002/eji.1830180427

Helle, 1988, Interleukin 6 is involved in interleukin 1-induced activities, Eur. J. Immunol., 18, 957, 10.1002/eji.1830180619

Waage, 1989, Interleukin-6 in synovial fluid from patients with arthritis, Clin. Immunol. Immunopathol., 50, 394, 10.1016/0090-1229(89)90146-3

Houssiau, 1988, Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides, Arthritis Rheum., 31, 784, 10.1002/art.1780310614

Waage, 1989, The complex pattern of cytokines in serum from patients with meningococcal septic shock, J. Exp. Med., 169, 333, 10.1084/jem.169.1.333

Houssiau, 1988, Elevated levels of the 26 K human hybridoma growth factor (interleukin-6) in cerebrospinal fluid of patients with acute infection of the central nervous system, Clin. Exp. Immunol., 71, 320

Van Oers, 1988, Interleukin 6 (IL-6) in serum and urine of renal transplants recipients, Clin. Exp. Immunol., 71, 314

Wingfield, 1986, Purification and characterization of human interleukin-1 expressed in recombinant Escherichia coli, Eur. J. Biochem., 160, 491, 10.1111/j.1432-1033.1986.tb10066.x

Pennica, 1985, Cloning and expression in E. coli of the cDNA for murine tumor necrosis factor, 82, 6060

Aarden, 1987, Production of hybridoma growth factor by human monocytes, Eur. J. Immunol., 17, 1411, 10.1002/eji.1830171004

Kramer, 1986, Serum-free in vitro bioassay for the detection of tumor necrosis factor, J. Immunol. Methods, 93, 201, 10.1016/0022-1759(86)90189-4

Waage, 1988, Interleukin 1 potentiates the lethal effect of tumor necrosis factor/cachectin in mice, J. Exp. Med., 167, 1987, 10.1084/jem.167.6.1987

Espevik, 1986, A highly sensitive cell line, WEHI 164, clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes, J. Immunol. Methods, 95, 99, 10.1016/0022-1759(86)90322-4

Shalaby, 1989, Cytokine regulation of interleukin 6 production by human endothelial cells, Cell. Immunol., 121, 372, 10.1016/0008-8749(89)90036-1

Kettelhut, 1987, The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors, 84, 4273

Jablons, 1989, IL-6IFN-γ-2 as a circulating hormone: Induction by cytokine administration in humans, J. Immunol., 142, 1542, 10.4049/jimmunol.142.5.1542

Movat, 1987, Tumor necrosis factor and interleukin-1: Role in acute inflammation and microvascular injury, J. Lab. Clin. Med., 110, 668

Dinarello, 1987, The biology of interleukin 1 and comparison to tumor necrosis factor, Immunol. Lett., 16, 227, 10.1016/0165-2478(87)90151-9

Defilippi, 1987, Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor, 84, 4557

Flick, 1986, Pharmacolinetics of murine tumor necrosis factor, J. Immunopharmacol., 8, 89, 10.3109/08923978609031087

Movat, 1987, Acute inflammation and Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor: Synergistic action of the cytokines in the induction of inflammation and microvascular injury, Amer. J. Pathol., 129, 463

Sun, 1988, Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor, J. Clin. Invest., 81, 1328, 10.1172/JCI113459